Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
6 October 2016
Header
Header image
News

News

EFPIA Statement on the ENVI Committee’s Draft Report on EU Options for Improving Access to Medicines
06 October 2016

EFPIA notes the publication of the European Parliament’s ENVI Committee draft report on EU options for improving access to medicines. People all over Europe are living [...] Read more

News

EFPIA is recruiting an Assistant Manager
05 October 2016

Role: The assistant manager will support the teams of IP Policy and Data Protection and will work on a variety of topics related to the aforementioned [...] Read more

From our blog

From our blog

A healthier future in the pipeline – how coming medical innovations will bring benefits for patients and societies
06 October 2016 by Thomas Allvin

We are in the middle of an unprecedented boom for the research and development of new medicines and health technologies that have the potential to reshape completely healthcare in many areas. This is mainly the result of rapid developments in biology, biotechnology and medicine, the advent of big data and predictive analytics, advances in genomics and patient-tailored treatment solutions, but also increased expenditure on research and development. We are now starting to see the fruits of these developments make their way out of the laboratories to the bedsides of patients.

Read more

Events calendar

Events Calendar

EFPIA Health Collaboration Summit 2016 - A Healthier Future for Europe
From 09/11/2016 to 10/11/2016 (Brussels)

The event will bring together patient organisation representatives, healthcare professionals and industry leaders from across Europe to encourage dialogue and share best practice.

This year we will be focusing on the challenges and opportunities in developing a more outcomes-driven, sustainable approach to healthcare in Europe as well as optimal patient engagement throughout the lifecycle of a medicine.

Read more

Events Calendar

FT Global Pharmaceutical and Biotechnology Conference
From 15/11/2016 to 16/11/2016 (London, UK)

The FT Global Pharmaceutical and Biotechnology Conference, now in its 34th successful year, brings together life science companies, their health industry counterparts and emerging new industry entrants to review the key challenges facing the industry and the business models and transformation strategies that will be needed to survive and thrive in an industry in flux.

Transformational shifts in healthcare markets herald challenges as well as opportunities ahead for the global life science industry. Considerations around value and outcomes of drug and other medical interventions are becoming a part of the fabric of the industry as health technology assessment and integrated care models gain traction in a growing number of markets.

For more information, click here.

Read more

Events Calendar

Joint DIA/EFGCP/EMA Better Medicines for Children Conference 2016 on Optimisation of Drug Development for the Benefit of Children
From 10/10/2016 to 11/10/2016 (European Medicines Agency, London, United Kingdom)

Since 10 years of EU paediatric regulation, considerable progress has been made by all involved in paediatric research: companies, regulators, academia, healthcare professionals and patients. Many products have now obtained a paediatric indication and new data are produced on a daily basis. Nevertheless, many trials recruit slowly and drug development plans are not completed.

The aim of this conference is to discuss how drug development can be further optimised to the benefit of children’s health. This will include a discussion on what we have learned during these years of full operation of the EU paediatric regulation, new concepts and strategies for an integrated approach at each and every step of paediatric development.

To register, click here.

For more information about the programme, click here.

Read more

What we are reading

What we are reading

Academia and industry join forces in largest European initiative to investigate the value of β-amyloid brain scans as a diagnostic and therapeutic marker for Alzheimer’s disease
06 October 2016 (AMYPAD)

The members of the AMYPAD initiative today announced the start of a novel research initiative between academic and private research partners to investigate the value of β-amyloid using positron emission tomography (PET) imaging as a diagnostic and therapeutic marker for Alzheimer’s dementia. 

Read more

What we are reading

Blogs from the European Health Forum Gastein 2016
06 October 2016 (EHFG)

Read here a series of blogs focussing on the discussions held last week at the EHFG. 

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail